Population attributable fraction estimates of cardiovascular diseases in different levels of plasma total cholesterol in a large-scale cross-sectional study: a focus on prevention strategies and treatment coverage

Population attributable fraction estimates of cardiovascular diseases in different levels of plasma total cholesterol in a large-scale cross-sectional study: a focus on prevention strategies and treatment coverage

Purpose Cardiovascular diseases (CVDs) are the main cause of deaths among non-communicable diseases. Arguments about the best prevention strategy to control CVDs’ risk factors continue. We evaluated the population attributable fraction (PAF) of CVDs in different levels of plasma cholesterol. Methods...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of diabetes and metabolic disorders 2020-12, Vol.19 (2), p.1453-1463
Hauptverfasser: Azadnajafabad, Sina, Karimian, Maryam, Roshani, Shahin, Rezaei, Negar, Mohammadi, Esmaeil, Saeedi Moghaddam, Sahar, Ghasemi, Erfan, Sadeghi Morasa, Fatemeh, Rezaei, Nazila, Aminorroaya, Arya, Ghanbari, Ali, Nasserinejad, Maryam, Gorgani, Fateme, Larijani, Bagher, Farzadfar, Farshad
Format: Artikel
Sprache:eng
Schlagworte:
Analysis
Anticholesteremic agents
Cholesterol
Communicable diseases
Diabetes
Endocrinology
Heart diseases
Hypercholesterolemia
Infection control
Medical research
Medicine
Medicine & Public Health
Metabolic Diseases
Research Article
Stroke
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Purpose Cardiovascular diseases (CVDs) are the main cause of deaths among non-communicable diseases. Arguments about the best prevention strategy to control CVDs’ risk factors continue. We evaluated the population attributable fraction (PAF) of CVDs in different levels of plasma cholesterol. Methods Patients’ data were obtained from Iran STEPs 2016 study. In phase 0 we estimated PAF regardless of cholesterol levels and clinical factors. In phase 1 we calculated PAF based on three levels of cholesterol (
ISSN:2251-6581
2251-6581
DOI:10.1007/s40200-020-00673-3